Translate
Everest Medicines Ltd.
About
Everest Medicines Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 8 2026
Everest Medicines Signs Share Purchase Agreement with Hasten Biopharmaceuticals (Asia) Limited
Mar 30 2026
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
Mar 23 2026
Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize CARDAMYST™ (Etripamil) Nasal Spray in Greater China
Mar 18 2026
Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited
Mar 16 2026
Everest Medicines to Announce 2025 Full-Year Financial Results on March 26, 2026 and Hold Online Earnings Call
Recent Videos
Everest Medicines Limited 2025 annual report
Apr 24, 2026
Everest Medicines Limited 2025 annual report
Mar 29, 2026
Everest Medicines Signs Deal with Corxel Pharmaceuticals for Cardamyst Nasal Spray
Mar 25, 2026
🎥 Exploring China’s Healthcare Unicorns | Everest Medicines
Jan 16, 2026